| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Dec 18, 2025 | Roivant Sciences Ltd. | Director | Sell | 15.0 | -1,694,614 | -9.39% | ✗ | $39.1M |
| Nov 19, 2025 | Nov 21, 2025 | Roivant Sciences Ltd. | Director | Sell | 15.0 | -1,300,000 | -6.72% | ✗ | $26.3M |
| Sep 24, 2024 | Sep 26, 2024 | Roivant Sciences Ltd. | Director | Sell | 16.3 | -503,000 | -28.26% | ✗ | $5.9M |
| Aug 14, 2024 | Aug 16, 2024 | Arbutus Biopharma Corp | Director | Sell | 26.3 | -8,846 | -16.11% | ✗ | $32.6K |
| Sep 28, 2023 | Oct 2, 2023 | Roivant Sciences Ltd. | Director | Sell | 15.0 | -6,896,144 | -8.16% | ✗ | $79.7M |
| Nov 9, 2022 | Nov 14, 2022 | Roivant Sciences Ltd. | Director | Sell | 15.0 | -5,118,704 | -5.71% | ✗ | $18.6M |